Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane S Hocking

Showing results (321-330 of 333) with videos related to

Pageof 34
Sort By:
Vaccine|September 29, 2019
Prevalence of human papillomavirus in teenage heterosexual males following the implementation of female and male school-based vaccination in Australia: 2014-2017Eric P F Chow, Sepehr N Tabrizi, Christopher K Fairley, et al.
International Journal of Epidemiology|October 1, 2016
Cohort Profile: Ten to Men (the Australian Longitudinal Study on Male Health)Jane Pirkis, Dianne Currier, John Carlin, et al.
BMC Infectious Diseases|February 3, 2011
'The difference in determinants of Chlamydia trachomatis and Mycoplasma genitalium in a sample of young Australian women'Jennifer Walker, Christopher K Fairley, Catriona S Bradshaw, et al.
The Lancet. Microbe|March 27, 2025
Evolving patterns of macrolide and fluoroquinolone resistance in Mycoplasma genitalium: an updated systematic review and meta-analysisTeck-Phui Chua, Lenka A Vodstrcil, Gerald L Murray, et al.
Plos One|June 5, 2012
Chlamydia trachomatis incidence and re-infection among young women--behavioural and microbiological characteristicsJennifer Walker, Sepehr N Tabrizi, Christopher K Fairley, et al.
Vaccine|July 20, 2021
Human papillomavirus prevalence and risk factors among Australian women 9-12 years after vaccine program introductionHannah Shilling, Suzanne M Garland, Steph Atchison, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 10, 2013
Mycoplasma genitalium incidence, organism load, and treatment failure in a cohort of young Australian womenJennifer Walker, Christopher K Fairley, Catriona S Bradshaw, et al.
The New England Journal of Medicine|June 23, 2021
Azithromycin or Doxycycline for Asymptomatic Rectal <i>Chlamydia trachomatis</i>Andrew Lau, Fabian Y S Kong, Christopher K Fairley, et al.
Wellcome Open Research|February 16, 2026
An oropharyngeal gonorrhoea controlled human infection model: a provisional protocol using a novel <i>Neisseria gonorrhoeae</i> challenge strainEloise Williams, Georgina L Pollock, David J Price, et al.
The Lancet Regional Health. Western Pacific|July 2, 2024
Characterising HIV-1 transmission in Victoria, Australia: a molecular epidemiological studyGeorge Taiaroa, Doris Chibo, Sophie Herman, et al.
Pageof 34

Showing results (321-330 of 333) with videos related to

Sort By:
Pageof 34
Vaccine|September 29, 2019
Prevalence of human papillomavirus in teenage heterosexual males following the implementation of female and male school-based vaccination in Australia: 2014-2017Eric P F Chow, Sepehr N Tabrizi, Christopher K Fairley, et al.
International Journal of Epidemiology|October 1, 2016
Cohort Profile: Ten to Men (the Australian Longitudinal Study on Male Health)Jane Pirkis, Dianne Currier, John Carlin, et al.
BMC Infectious Diseases|February 3, 2011
'The difference in determinants of Chlamydia trachomatis and Mycoplasma genitalium in a sample of young Australian women'Jennifer Walker, Christopher K Fairley, Catriona S Bradshaw, et al.
The Lancet. Microbe|March 27, 2025
Evolving patterns of macrolide and fluoroquinolone resistance in Mycoplasma genitalium: an updated systematic review and meta-analysisTeck-Phui Chua, Lenka A Vodstrcil, Gerald L Murray, et al.
Plos One|June 5, 2012
Chlamydia trachomatis incidence and re-infection among young women--behavioural and microbiological characteristicsJennifer Walker, Sepehr N Tabrizi, Christopher K Fairley, et al.
Vaccine|July 20, 2021
Human papillomavirus prevalence and risk factors among Australian women 9-12 years after vaccine program introductionHannah Shilling, Suzanne M Garland, Steph Atchison, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 10, 2013
Mycoplasma genitalium incidence, organism load, and treatment failure in a cohort of young Australian womenJennifer Walker, Christopher K Fairley, Catriona S Bradshaw, et al.
The New England Journal of Medicine|June 23, 2021
Azithromycin or Doxycycline for Asymptomatic Rectal <i>Chlamydia trachomatis</i>Andrew Lau, Fabian Y S Kong, Christopher K Fairley, et al.
Wellcome Open Research|February 16, 2026
An oropharyngeal gonorrhoea controlled human infection model: a provisional protocol using a novel <i>Neisseria gonorrhoeae</i> challenge strainEloise Williams, Georgina L Pollock, David J Price, et al.
The Lancet Regional Health. Western Pacific|July 2, 2024
Characterising HIV-1 transmission in Victoria, Australia: a molecular epidemiological studyGeorge Taiaroa, Doris Chibo, Sophie Herman, et al.
Pageof 34